ular location of the main yGT isoenzymes have been put forward by Hetland et al. (1975) , who have suggested that the ui-migrating isoenzyme might be the induced microsomal enzyme (although work by Kok et al. (1978) has not supported this view), that .the u2"migrating enzyme might be the result of . parenchymal lysis, and that the p-migrating enzyme might result from impaired biliary secretion of yOT.
SUMMARY Simultaneous localisation of the isoenzymes of alkaline phosphatase and y-glutamyl transferase was carried out on 173 serum samples from patients with hepatobiliary and bone disease to determine (i) if a better discrimination of the underlying pathology could be obtained by such an approacb, and (ii) if the pathology suggested by the alkaline phosphatase isoenzyme separation could help in determining the cellular location of the y-glutamyl transferase isoenzymes, It was found that the localisation of the y-glutamyl transferase isoenzymes had, with a few exceptions, little advantage over the measurement of the total activity but that some evidence concerning the cellular location of the y-glutamyl transferase isoenzymes could be gained by such an approach. There was support for the view that the (X2-migrating isoenzyme is derived from the liver parenchymal cytoplasm, but little support for the view that the (Xl-migrating isoenzyme is predominantly the induced microsomal enzyme or that the p-migrating isoenzyme is the result of impaired billiary secretion.
There have been conflicting views about the clinical usefulness of the identification of y-glutamyl transferase (yOT, E.C.2.3.2.1) isoenzymes in serum from those who believe the technique to have little diagnostic value (Kokot and Ruska, 1965; Azzopardi and Jayle, 1973) to those who see the technique to be of use in the differential diagnosis of diseases of the hepatobiliary system (Miyazaki' and Okumura, 1972; Bruch Igartua et al., 1973; Hetland et aI., 1975; Burlina, 1978) . At least some of the criticism regarding the clinical usefulness of the isoenzyme separation may have resulted from the fact that these have been studied in isolation and not as part of a multi analytical approach where they might provide information additional to that gathered simultaneously from other sources. Localisation of alkaline phosphatase (ALP, E.C.3.!.3.1) isoenzymes is now a well-recognised technique for the identification of the tissue source of the raised activity and Material and methods can also provide information regarding the nature of the pathology in the case of the liver isoenzyme SUBJECTS (Price and Sammons, 1974) .
Serum samples were obtained from 173 hospital In the present work the isoenzymes of ALP and inpatients with diseases of the hepatobiliary system yOT were determined simultaneously to see if a and other disorders resulting in an increase in the better discrimination of the underlying pathology activity of ALP or yOT. The clinical diagnosis on could be obtained and to investigate if the pathology each patient was established, where possible, by suggested by the ALP isoenzyme separation could means of clinical and laboratory observations, by help to determine the cellular location of the yGT tissue biopsy. or by radiological investigation. isoenzymes. Postulations regarding the possible cell-Serum samples from patients without any evidence 20 of hepatobiliary or bone disease were used to provide reference isoenzyme patterns.
METHODS
Electrophoresis was carried out on Cellogel strips, 5·7 x 14 cm (Whatman Ltd Maidstone, Kent) in a tris-sodium barbitone-barbitone buffer (pH 8'8, I = 0'047) at a constant voltage of 200 v for 1 hour. A 10 IIIsample was applied at the origin 2·5 ern from one end, and three strips were included in each run. When electrophoresis had finished each strip was cut longitudinally into strips of width 2 ern, 1·7 em, and 2 ern, and these were treated as follows: (i) The central strip was stained for proteins with Ponceau Red S (4g/l, in trichloroacetic acid (50gfl) ).
(ii) The left-hand strip was stained for ALP activity by the method of Burlina and Galzigna (1976) , except that Fast Garnet GBC salt (Gurr, Searle Diagnostics, High Wycombe, Bucks) was preferred as the chromogen. (iii) The right-hand strip was stained for yGT activity by the method of Burlina (1978) . After staining, all strips were washed with 5 % acetic acid and aligned at the common origin for interpretation. A series of 21 blank separations, omitting the respective substrate, did not show any staining for ALP or yGT.
Total ALP activity was measured by reaction rate analysis at 37°C, using a Gilford 3400 N Analyser (Gilford Instruments Ltd, Teddington, Middlesex), p-nitrophenyl phosphate as a substrate (final concentration, 5·2 mv) and 2-amino 2-methyl I, 3-propanediol as buffer (0'625 M, pH 10'25). The heatstable fraction of the serum was calculated by measuring the activity before and after heating at 56°C for 10 minutes. A heat stability of less than 18 % was taken to indicate a predominantly bone isoenzyme, and of greater than 34 % to indicate a predominantly liver isoenzyme (Burlina and Galzigna, 1976) .
Total yGT activity was measured at 3rC on a Gilford 3400 Enzyme Analyser by the method of Rosalki and Tarlow (1974) except that the final concentration of the substrate, y-glutamyl-p-nitroanilide, was reduced to 3'2 mMas suggested by Tarbit (1975) . The reference range for an adult population in this laboratory is up to 48 VII for male subjects and up to 45 VII for female subjects.
Results
The isoenzyme patterns were interpreted by reference to their simultaneous protein separation. The ALP isoenzyme bands coincided exactly with the protein bands and bands corresponding to the al-, a2-, pre-B>, and 132-globulins were seen. Samples from patients without any evidence of hepatobiliary or bone disease, and with normal total ALP activity showed a single a2-band with occasionally a lh-(intestinal) band. In pathological samples the a2-band was further differentiated into a narrow band, indicating a liver source, and a broad band, indicating a bone source. The aI-band was considered to represent the biliary enzyme, and the pre-l3-band the placental or Regan isoenzyme (Rosalki, 1976) .
It was found that the yGT isoenzyme bands only rarely corresponded exactly with the protein band and varied from sample to sample with regard to the position of the band relative to the protein band. The isoenzymes were therefore divided into zones of activity in a manner similar to that used by Patel and O'Gorman (1973) except that their discrete a2-band was excluded from this classification. The zones used were pre-albumin up to and including Albumin (Pre A-A), albumin up to and including nr-globulln (A-al), aI-globulin up to and including a2-g10bulin (al-a2), a2-globulin up to and including 131-globulin (cs -(31), 131-globulin up to and including y-globulin (131 -y) and an origin band (0). Samples from patients with normal yGT activity all showed faint staining in the al -a2 region, and some had A -al staining also. Typical isoenzyme separations are shown in the Figure. The yGT isoenzyme patterns so classified were then considered in relation to the corresponding ALP isoenzyme patterns, which were divided into four groups as follows:
The 'bone' group. These were serum samples with a heat stability of the ALP activity of less than 18% and no aI-ALP band.
GROUP 2
The 'obstructive' liver group. These were serum samples having a heat stability of greater than 34 % together with an aI-band.
GROUP 3
The 'hepatocellular' liver group. These were serum samples having a heat stability of greater than 34 % without an ul-band.
GROUP 4
The 'miscellaneous' group. These were samples having a heat stability between 18 % and 34 %. Table 1 shows the incidence of each yGT isoenzyme zone in the four groups together with the range of activity encountered. In Table 2 the incidence of the yGT isoenzymes is considered in relation to the clinical diagnosis for 10 diagnostic groups, together with the incidence of the ALP biliary isoenzyme and the ratio of a2-and al-yGT bands. 
and ALP-a.t (LHS) together with a gross increase in the yGT-a.. and smaller activities ofyGT-a.t and yGT-P. (RHS). (4) A sample from a patient with pancreatitis showing a single ALP-a.1 band together with a dominant yGT-a.\ band. a diffuse yGT-a.t band. and very little P staining.

Discussion
In the liver, yGT exists in two forms, a soluble form of low molecular weight which occurs in the cell sap, and the more predominant high molecular weight membrane-bound microsomal component. Histochemically, the enzyme has been demonstrated in the canaliculi of the parenchyma and in the luminal border of the epithelial cells of the biliary ductules (Rosalki, 1975) . Possible intracellular sources of the isoenzymes of yGT have been suggested by Hetland et al. (1975) , but recent work has not supported parts of this hypothesis (Kok et al., 1978) .
From Table 1 it can be seen that the A -ci band (yGT -Ul) is present in almost all sera, and Table 2 shows a 100% incidence of the yGT -Ul band in all the groups studied, not just in alcoholism where enzyme induction is to be expected, but in diseases such as primary biliary cirrhosis, chronic active hepatitis, and congestive cardiac failure. This finding does not accord with the view that the yGT -Ul isoenzyme is predominantly the induced microsomal enzyme (Hetland et al., 1975 ) but agrees with the universal incidence of the yGT -Ul band reported by Bruch Igartua et al. (1973) and supports the findings of Kok et al. (1978) , who could not differentiate between patients with a raised total yGT activity due to treatment with antiepileptic drugs and those with liver parenchymal lesions, on the basis of an increase in the yGT-ullevel. There is, however, some support from Table 1 for the suggestion of Hetland et al. that the yGT -U2 isoenzyme might be the result of liver parenchymal lysis. The incidence of the yGT -U2 band in the hepa-tocellular group, at 83 %, is higher than the incidence in the obstructive group (63 %) although this incidence is matched by the miscellaneous group (84 %).
Such an incidence in the miscellaneous group would not, however, preclude a parenchymal source for the yGT -U2 isoenzyme as many patients in this group would have liver cellular damage. The balance of the evidence, therefore, is in support of the hypothesis.
With regard to the incidence of the u2-lh (yGTIh) bands, Table 1 shows that an equal incidence (67 %) was obtained in both the obstructive and hepatocellular groups, thus allowing no differentiation between the two. There is thus little support for the hypothesis that the yGT~131 activity may result from impaired biliary secretion of yGT, because if this were the case then a higher incidence would be expected in the obstructive group as opposed to the hepatocellular group. Table 2 also shows evidence which conflicts with the suggested link between yGT -131 and impaired biliary secretion, as there is a very poor correlation between the incidence of the alkaline phosphatase ul-(biliary) band (ALP-Ul) and the yGT -131 band. Thus seven patients with alcoholism have a 100 % incidence of yGT -131
bands and yet have no ALP~Ul band, and, conversely, the group of patients with congestive cardiac failure have a 100% incidence of ALP-rl1 tuilds (indicating intrahepatic obstruction) but a low incidence (29%) of yO'; -I', bands.
It is clear from Table 2 cnat it would be very difficult to assign a specific yGT isoenzyme pattern to a definite diagnostic group as all groups show a dominant yGT -Ul band (denoted by a very low incidence of a yGT -u2/yGT -Ul ratio of greater than one), and a high proportion in all groups show yGT-U2 and yGT-131 activity also. Furthermore, the incidence of the less common bands pre A-A (yGT -A) and 131-y (yGT -y) is also unhelpful, their occurrence being almost randomly spread among the different diagnostic groups. The only pattern which might be sufficiently distinct to have clinical use is the increase of the yGT -131 band at the expense of the yGT -U2 band, as noted in cases of cholangitis and carcinoma of pancreas.
In contrast to the findings of some authors, the appearance of a yGT -u2/yGT -Ul ratio of greater than one, the 'reversed ratio', is uncommon in this series, being confined to only two patients of the 68 in the major diagnostic groups described in Table 2 . Miyazaki and Okumura (1972) reported a reversed ratio in two cases of primary biliary cirrhosis and in four cases of pancreatic tumour using agar gel electrophoresis, but in the four cases each of primary biliary cirrhosis and carcinoma of the pancreas described here, no incidence of a reversed ratio was Baines found. Bruch Igartua et al. (1973) , using cellulose acetate gel as support medium, found an increased incidence (16 cases out of 20) of reversed ratio in a group of patients with diseases of the liver parenchyma without involvement of the extrahepatic biliary tract, but the findings in this work are more in agreement with those of Kok et al. (1978) , who found only one case of reversed ratio in a group of 22 patients with liver parenchymal lesions and an elevated total yGT activity.
The conclusions of the present study are, therefore, that yGT isoenzyme analysis, either alone or together with an alkaline phosphatase isoenzyme separation, has little advantage over the measurement of total yGT activity in the differential diagnosis of disease states. There are few specific cases where further information might be gained by isoenzyme analysis, and cost effectiveness considerations would strongly support the measurement of total activity only. However, the simultaneous analysis of A LP isoenzymes with those of yGT might help in some way to elucidate the possible cellular location of the yGT isoenzymes. There is support from this study for the hypothesis that the yGT -U2 isoenzyme is derived from the parenchymal cytoplasm, but little evidence to support the views that the yGT -Ul isoenzyme is predominantly the induced microsomal enzyme, or that the yGT -131 is the product of the biliary tract epithelial cells. Further work is needed to define the cellular locations of these isoenzymes if they are to be of more use in the differentiation of disease states.
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